Publication date: Jun 25, 2019
Persons with opioid use disorder (OUD) hospitalized with severe, injection-related infections (SIRI) are frequently hospitalized for the duration of IV antibiotic treatment due to concerns regarding their eligibility for outpatient parenteral antimicrobial therapy (OPAT), which is the standard of care for prolonged IV antibiotic courses for patients without drug use. As part of a pilot study, a novel, integrated care model was developed where patients with OUD and SIRI receive addiction consultation and buprenorphine induction while hospitalized, followed by ongoing management in an outpatient clinic that combines office-based opioid treatment with buprenorphine pharmacotherapy and counseling services with OPAT. Through three illustrative case vignettes the outpatient model is described along with challenges, lessons learned and future directions.
Fanucchi, L.C., Walsh, S.L., Thornton, A.C., and Lofwall. Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model. 03686. 2019 Prev Med.
- Opioid Epidemic Causing Increase in Hepatitis, HIV Infections, and Infective Endocarditis
- The past, present and future of opioid withdrawal assessment: a scoping review of scales and technologies.